This is an obsolete version of the rule. Please click on the rule number to view the current version.

37.114.101    DEFINITIONS

Unless otherwise indicated, the following definitions apply throughout this chapter:

(1) "Case" means a person who is confirmed or suspected to have a reportable disease or condition as listed in ARM 37.114.203.

(2) "Clean" means to remove infectious agents and/or organic matter from surfaces on which and in which infectious agents and/or organic matter may be able to live and remain virulent, by scrubbing and washing as with hot water and soap or detergent.

(3) "Communicable disease" means an illness due or suspected to be due to a specific infectious agent or its toxic products, which results from transmission of that agent or its products to a susceptible host, directly or indirectly.

(4) "Concurrent disinfection" means the use of a method which will destroy any harmful infectious agents present immediately after the discharge of infectious material from the body of an infected person, or after the soiling of articles with such infectious discharges before there is opportunity for any other contact with them.

(5) "Contact" means a person or animal that may have had an opportunity to acquire an infection due to the contact's association with a suspected or confirmed infected person or animal or a contaminated environment.

(6) "Contamination" means the presence of a disease-causing agent upon a living body surface or within or upon any inanimate article or substance.

(7) "Control of Communicable Diseases Manual" means the "Control of Communicable Diseases Manual, An Official Report of the American Public Health Association", (18th edition, 2004). A copy of the "Control of Communicable Diseases Manual" may be obtained from the American Public Health Association, 800 I Street NW, Washington, DC 20001.

(8) "Department" means the Department of Public Health and Human Services.

(9) "Guideline for Isolation Precautions in Hospitals" means the guideline published by the federal Government Printing Office. A copy of the guideline may be obtained from the National Technical Information Service, U.S. Department of Commerce, 5285 Port Royal Road, Springfield, Virginia 22161, phone: (703)487-4650. Any orders should refer to the publication number PB96138102 for the "Guideline for Isolation Precautions in Hospitals" (1996).

(10) "Health care" means health care as defined in 50-16-504 , MCA.

(11) "Health care facility" is a facility as defined in 50-5-101 , MCA.

(12) "Health care provider" means a health care provider as defined in 50-16-504 , MCA.

(13) "HIV infection" means infection with the human immunodeficiency virus.

(14) "Household contact" is a person or animal living within the household of an infected person.

(15) "Infected person" means a person who harbors an infectious agent whether or not illness is currently discernible.

(16) "Infection" means the entry and development or multiplication of an infectious agent in the body of man or animals.

(17) "Infection control precautions" means those measures necessary to prevent the transmission of disease from an infected person to another person, taking into consideration the specific suspected or confirmed communicable disease and the specific circumstances of the case. The infection control precautions required for a case admitted to a hospital or other health care facility are those measures identified as isolation precautions applicable to the specific disease in the "Guideline for Isolation Precautions in Hospitals" (1996) adopted in ARM 37.114.105. The infection control precautions required for a case not admitted to a hospital or other health care facility are those measures identified as methods of control applicable to the specific disease in the "Control of Communicable Diseases Manual, An Official Report of the American Public Health Association", (18th edition, 2004), adopted in ARM 37.114.105. Infection control precautions are required, as stated in this rule, whether or not the person is subject to isolation.

(18) "Infectious agent" means an organism, chiefly a microorganism, but including helminths, that is capable of producing an infection or infectious disease.

(19) "Infectious disease" means a clinically manifest disease of man or animals resulting from an infection.

(20) "Infectious person" means a person from whom another person may acquire an infectious agent by touch or proximity.

(21) "Isolation" means separation during the period of communicability of an infected or probably infected person from other persons, in places and under conditions approved by the department or local health officer and with observance of all applicable infection control precautions.

(22) "Laboratorian" means any person who supervises or works in a laboratory.

(23) "Local health officer" means a county, city, city-county, or district health officer appointed by a local board of health. As used in these rules, the term will include the authorized representative of a local health officer.

(24) "Outbreak" means an incidence of a disease or infection significantly exceeding the incidence normally observed in a population of people over a period of time specific to the disease or infection in question.

(25) "Physician" means a person licensed to practice medicine in any jurisdiction in the United States or Canada.

(26) "Potential outbreak" means the presence or suspected presence of a communicable disease in a population where the number of susceptible persons and the mode of transmission of the disease may cause further spread of that disease.

(27) "Quarantine" means those measures required by a local health officer or the department to prevent transmission of disease to or by those individuals who have been or are otherwise likely to be in contact with an individual with a communicable disease.

(28) "Reportable disease" means any disease, the occurrence or suspected occurrence of which is required to be reported by ARM 37.114.203.

(29) "Sensitive occupation" means an occupation described in ARM 37.114.301.

(30) "Sexually transmitted disease" means human immunodeficiency virus (HIV) infection, syphilis, gonorrhea, chancroid, lymphogranuloma venereum, granuloma inguinale, or chlamydial genital infections.

(31) "Sexually Transmitted Diseases Treatment Guidelines 2002" means the guidelines published by the U.S. Centers for Disease Control and Prevention. A copy of the 2002 guidelines is available from the Department of Public Health and Human Services, Public Health and Safety Division, HIV/STD Section, 1400 Broadway, P.O. Box 202951, Helena, MT 59620-2951, phone: (406)444-3565.

(32) "Surveillance" means scrutiny of all aspects of occurrence and spread of a disease that are pertinent to effective control.

(33) "Susceptible" means having insufficient resistance against a disease and likely to contract the disease if exposed.

History: 50-1-202, 50-2-116, 50-17-103, MCA; IMP, 50-1-202, 50-17-103, 50-18-101, MCA; NEW, 1980 MAR p. 1579, Eff. 6/13/80; AMD, 1987 MAR p. 2147, Eff. 11/28/87; AMD, 1995 MAR p. 1127, Eff. 6/30/95; AMD, 1998 MAR p. 2493, Eff. 9/11/98; AMD, 2000 MAR p. 2986, Eff. 9/22/00; TRANS, from DHES, 2002 MAR p. 913; AMD, 2006 MAR p. 2112, Eff. 9/8/06.

Home  |   Search  |   About Us  |   Contact Us  |   Help  |   Disclaimer  |   Privacy & Security